APAC IPOs & Placements, Aequitas Research

Rosita Fernandes

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%

APAC IPOs & Placements

Veeda Clinical Research Pre-IPO - Positioned for Growth Amid Financial Risks

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Veeda Clinical Research Ltd / Equity Capital Markets

Veeda Clinical Research Ltd (3340714Z IN)

<ul>
<li>
<a href="https://www.smartkarma.com/entities/veeda-clinical-research-ltd" target="_blank" data-smartkarma-citation="entities:44330:1" rel="noopener">Veeda Clinical Research Ltd (3340714Z IN)</a>  (VCRL) is looking to raise about US$115m in its upcoming India IPO. The bookrunners for the deal are Axis, CLSA, IIFL, SBI.</li>
<li>VCRL is a global contract research organization offering comprehensive drug development services, including non-clinical, pre-clinical, clinical trials, and studies across diverse drug types like generics, biosimilars, and medical devices.</li>
<li>The company operates in key global markets, including North America, Europe, and Asia, with a presence in India.</li>
</ul>



Veeda Clinical Research Ltd (3340714Z IN)  (VCRL) is looking to raise about US$115m in its upcoming India IPO. The bookrunners for the deal are Axis, CLSA, IIFL, SBI.
VCRL is a global contract research organization offering comprehensive drug development services, including non-clinical, pre-clinical, clinical trials, and studies across diverse drug types like generics, biosimilars, and medical devices.
The company operates in key global markets, including North America, Europe, and Asia, with a presence in India.


Veeda Clinical Research Ltd Pre-IPO Tearsheet